Icoria to ID Biomarkers for Isis Pharmaceuticals | GenomeWeb

Icoria to ID Biomarkers for Isis Pharmaceuticals

Aug 24, 2005

NEW YORK, Aug. 24 (GenomeWeb News) - Icoria will identify biomarkers of toxicity in animal models for Isis Pharmaceuticals, the biotechnology company said yesterday.

Icoria will use its metabolomics platform to evaluate differences in treated and untreated animal subjects to identify biomarkers that Isis will use to suggest pathways for alteration by potential drug candidates, Icoria said.

Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.